Compliance, coercion, and compassion: Moral dimensions of the return of tuberculosis

Journal of Medical Humanities

Volumn 17, Issue 2, 1996, Pages 91-102

  Booker, Michael J ^a  

^a Roane State Community College   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

ARTICLE; CENTERS FOR DISEASE CONTROL AND PREVENTION; COMMUNICABLE DISEASE; FORENSIC PSYCHIATRY; GOVERNMENT; HEALTH CARE AND PUBLIC HEALTH; HUMAN; HUMAN RIGHTS; INFECTION CONTROL; JURISPRUDENCE; MANDATORY PROGRAM; PATIENT CARE; PATIENT COMPLIANCE; PERSUASIVE COMMUNICATION; POLICY; PUBLIC HEALTH; PUBLIC HEALTH SERVICE; SOCIOECONOMICS; TUBERCULOSIS; UNITED STATES;

CENTERS FOR DISEASE CONTROL AND PREVENTION; HEALTH CARE AND PUBLIC HEALTH;

CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); COERCION; COMMITMENT OF MENTALLY ILL; COMMUNICABLE DISEASES; FEDERAL GOVERNMENT; GOVERNMENT; HUMAN RIGHTS; HUMANS; JURISPRUDENCE; MANDATORY PROGRAMS; PATIENT CARE; PATIENT COMPLIANCE; PHARMACEUTICAL PREPARATIONS; PUBLIC HEALTH; PUBLIC POLICY; QUARANTINE; SOCIOECONOMIC FACTORS; STATE GOVERNMENT; TUBERCULOSIS; UNITED STATES;

EID: 0030153445     PISSN: 10413545     EISSN: 15733645     Source Type: Journal    
DOI: 10.1007/BF02276811     Document Type: Article

References (46)

1. One typical quote: "Tuberculosis is now a conquered disease in the British Isles and the rest of the Industrialized [sic] world" (Smith FB. The Retreat of Tuberculosis, 1850-1950. London: Croon Helm, 1988. 2.).
2. Myers JA. Captain of All These Men of Death. St. Louis: Warren H. Green, Inc., 1977. 237-240.
3. Bloom BR, Murray CJL. Tuberculosis: commentary on a reemergent killer. Science 1992; 257:1055-1064. 1060.
4. The most recent CDC data on tuberculosis does show a 5% decrease in new cases from 1992 to 1993 (from 26,673 new cases to 25,313); however, this data is currently under review. Centers for Disease Control and Prevention. Expanded tuberculosis surveillance and tuberculosis morbidity - United States, 1993. Morbidity and Mortality Weekly Report 1994; Vol.43/No. 20:361-366.
5. Stoeckle MY, Douglas RG Jr. Infectious disease. Journal of the American Medical Association 1993; 270:223-224. 223. The authors state here that "[s]ome strains of MDR-TB are resistant to all anti-TB medications." A telephone conversation with Dr. Stoeckle clarified this statement as follows: In the case of a few highly drug-resistant strains of MDR-TB, the bacteria still show susceptibility to a few anti-TB medications, but in clinical use the drugs can simply be ineffective and the disease progresses unchecked.
6. Centers for Disease Control and Prevention. Management of persons exposed to multidrug-resistant tuberculosis. Morbidity and Mortality Weekly Report 1992; Vol. 41/No. RR-1:59-71. 66.
7. Myers. 237-240. Similar figures are also given in: Fowler, Sir JK Pulmonary Tuberculosis. London: Macmillan and Co., Limited, 1921. 43-44. Not surprisingly, the mortality rate for MDR-TB seems to follow the earlier mortality rates for untreated tuberculosis (see Bloom and Murray. 1056.).
8. Study finds TB danger even in low-risk groups. New York Times, 18 October, 1992.
9. Bloom and Murray. 1063.
10. Small PM, Hopewell PC, Singh SP, Paz A, Parsonnet J, Ruston DC, Schecter GF, Daley CL, Schoolnik GK. The Epidemiology of Tuberculosis in San Francisco. New England Journal of Medicine 1994; 330:1703-1709.
11. Villarino ME, Geiter LJ, Simone PM. The multidrug-resistant tuberculosis challenge to public health efforts to control tuberculosis. Public Health Report 1992; 107:616-625. 617.
12. Similar probabilities are reported in Pust. 588.
13. Centers for Disease Control and Prevention. National action plan to combat multidrug-resistant tuberculosis. Morbidity and Mortality Weekly Report 1992; Vol. 41/No. RR-11:1-47. 7.
14. Pust RE. Tuberculosis in the 1990s: resurgence, regimens and resources. Southern Medical Journal 1992 85:584-593. 591.
15. Brudney K, Dobkin J. Resurgent tuberculosis in New York City. American Review of Respiratory Disease 1991; 144:745-750. 747.
16. Bloom and Murray. 1059.
17. Two excellent histories of the control of tuberculosis are: Caldwell M. The Last Crusade. New York: Atheneum, 1988;
18. and Dubos R, Dubos J. The White Plague. Boston: Little, Brown and Company, 1952.
19. In 1867, JA. Villemin was the first scientist to experimentally demonstrate that tuberculosis was communicable. The tuberculosis bacterium was isolated and identified by Robert Koch in 1882.
20. U.S. Bureau of the Census. Historical Statistics of the United States, Colonial Times to 1970, Bicentennial Edition, Part 2. Washington D.C.: U.S. Government Printing Office, 1975. 58, 77 and 78.
21. Centers for Disease Control and Prevention. National action plan to combat multidrug-resistant tuberculosis. Morbidity and Mortality Weekly Report 1992; Vol. 41/No. RR-11:1-47.
22. Problems/Objectives 1-4, 7, 14, 17, 19, 21, and 22.
23. Caldwell. 194.
24. Gostin LO. Controlling the resurgent tuberculosis epidemic. Journal of the American Medical Association 1993; 269:255-261. 260.
25. Problems/Objectives 24, 25, and 32-38.
26. Problems/Objectives 5, 6, 10-13, 15-17, and 22.
27. United Hospital Fund of New York. The Tuberculosis Revival: Individual Rights and Societal Obligations in a Time of AIDS. New York: United Hospital Fund of New York, 1993. 56.
28. Problems/Objectives 8, 9, and 20 deal with Directly Observed Treatment; Problem/Objective 14 deals with involuntary isolation.
29. Iseman MD, Cohn DL, Sbarbaro JA. Directly observed treatment of tuberculosis: we can't afford not to try it. New England Journal of Medicine 1993; vol. 328, No. 8:576-578.
30. Brudney and Dobkin. 748.
31. Iseman, Cohn, Sbarbaro. See also Weis SE, Slocum PC, Biais FX, King B, Nunn M, Matney GB, Gomez E, Foresman BH. The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. New England Journal of Medicine 1994; Vol. 330, No. 17:1179-1184.
32. Centers for Disease Control and Prevention. Initial therapy for tuberculosis in the era of multidrug resistance: recommendations of the Advisory Council for the Elimination of Tuberculosis. Morbidity and Mortality Weekly Report 1993; Vol. 42/No. RR-7:1-8. 6.
33. United Hospital Fund of New York. 24-25.
34. Iseman, Cohn, Sbarbaro. 577.
35. Gostin. 260.
36. Annas G. J. Control of tuberculosis - the law and the public's health, New England Journal of Medicine 1993; vol. 328, No. 8:585-588. 587.
37. Gostin. 259-260. Annas. 587-588.
38. Annas elaborates on this point in a letter to the editor printed in the New England Journal of Medicine 1993; vol. 329, No. 2:137-138.
39. Reichman, LB, Mangura, BT. To the editor. New England Journal of Medicine 1993; vol. 329, No. 2:137.
40. At present, approximately $35.00 per test.
41. Rothman, SM. Living in the Shadow of Death. New York: Basic Books, 1994. 252.
42. Iseman, Cohn, Sbarbaro. 576.
43. Gostin. 256-258.
44. United Hospital Fund of New York. 31.
45. Harris and Holm suggest that our relatively lenient treatment of AIDS is largely a product of the disease's epidemiology, not our social progress (Harris J, Holm S. If only AIDS were different Hastings Center Report 1993; vol. 23, No. 6:6-12.).
46. Brudney, Dobkin. 748.